Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing surgical conditions during laparoscopic hernia repair with deep neuromuscular blockade
2014-002802-19Phase 4Completed
- Sponsor
- Department of Anaesthesiology
- Start
- Jul 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Sugammadex and rocuronium in umbilical hernia, incisional hernia and epigastric hernia (2 arms), sponsored by Department of Anaesthesiology. Primary endpoint: Surgeon's rating of surgical conditions while suturing the hernia. Started Jul 2014; status: completed.
02
Drugs
Sugammadexrocuronium
03
Conditions
umbilical herniaincisional herniaepigastric hernia
Beyond the preview
Go deeper on 2014-002802-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002802-19.